European Archives - Page 1601 of 1607 - European Medical Journal

The Changing Landscape in Oral Anticoagulation - The Last Pieces of the Puzzle

Dabigatran, rivaroxaban, apixaban and edoxaban are four new oral anticoagulants (NOACs). There are an increasing number of indications for which these…

Practical Guidance for Stroke Prevention in Atrial Fibrillation – Interactive Case Studies

This Boehringer Ingelheim sponsored satellite symposium was held on 2nd September 2013 as part of the ESC conference, which was hosted this year in…

Managing Thromboembolic Risks of Atrial Fibrillation: Can We Afford Increased Efficacy of the Novel Anticoagulants and Devices?

Ischaemic/embolic complications are the most common severe consequences of atrial fibrillation. Although chronic anticoagulation with warfarin has been…

Atrial Fibrillation in Childhood with Familial Hyperthyroidism in Afro-Caribbeans

Atrial fibrillation (AF) associated with familial hyperthyroidism (FH) spanning three generations concomitantly, is rare. The index case was 10 years old…

Consistency Versus Equity – Cardiovascular Disease Management For South Asians in the United Kingdom

An increased risk of coronary heart disease was an immediate healthcare concern following the mass arrival of South Asian immigrants to the UK, and it…

Prescribing Physical Activity for the Prevention and Treatment of Hypertension in Patients with Aortic Coarctation - A Review

Patients who have been treated for aortic coarctation (CoA) have increased late cardiovascular morbidity and mortality, which is partly due to the…

Initial Evidence in Thromboangiitis Obliterans (Buerger’s Disease) Treatment with Bosentan

Thromboangiitis obliterans (TAO) is a vascular disease that affects small and medium-sized arteries and veins of both upper and lower extremities. Distal…

Nationwide Family Studies of Cardiovascular Diseases - Clinical and Genetic Implications of Family History

Studies of family history (FH) have long been used to estimate the heritability of cardiovascular diseases (CVDs). Genome-wide association studies (GWAS)…

The Benefits of Rivaroxaban (Xarelto®) Across Multiple Indications and the Relevance to Cardiologists

Oral anticoagulation with vitamin-K-antagonists has well known limitations and requires routine clinical monitoring of coagulation parameters. The new…

EMJ Respiratory 2013

It gives me great pleasure to welcome you to the debut edition of EMJ – Respiratory. This journal is our biggest to date, and includes the EMJ…